Beyond the limits of life,
through genome editing
Built on our CRISPR-Cas9 foundational technology, ToolGen tackles humanity's hardest problems across food (Green Bio), health (Red Bio) and energy (White Bio).
1st
First in the world
25Y
Years of research
3Bio
Health · Food · Energy
70+
Research specialists
Mission
Through genome editing, we improve quality of life and pave the way for a sustainable future. We create real value beyond research in health, climate, and food.
Vision
We lead therapeutic and seed innovation from core tech, ultimately preparing a world in which humanity transcends limits and thrives amid challenges.
Secure Core Tech
Bench to Field
Trusted Gene Editor
Sustainable Value
Core Value
Integrity & Trust
Freedom & Ownership
Open Collaboration
Sustainable Future
Three bios, one platform
CRISPR-Cas9 원천기술이 인류의 식량·건강·에너지 전반으로 확장됩니다. 영역에 마우스를 올려 살펴보세요.
Red Bio
Health · Therapeutics
Treating intractable diseases at their root with CRISPR-Cas9 genome editing therapeutics.
Learn more →Green Bio
Food · Seeds
Addressing global food challenges with functional, high-yield crops and next-generation seeds.
Learn more →White Bio
Energy · SAF
Extending the genome editing platform into bio energy and materials such as sustainable aviation fuel (SAF).
Learn more →From research to market
| Program | Indication / target | Stage | Area |
|---|---|---|---|
| GEB-200 | CRISPR-Based Lp(a) Suppression | Cardiovascular | IND-enabling | Red Bio |
| TGT-202 | Liver Biofactory Platform, LBP | Liver | POC | Red Bio |
| TGT-201 | Hemophilia A & B (Including Inhibitors) | Liver | in vivo | Red Bio |
| Styx-T Platform-1 | Next-Generation CAR-T | Immune cell | POC | Red Bio |
Investors and latest news
Considering genome editing
for your programme?
From licensing and joint research to contract services, ToolGen's specialists work alongside you.